Phillip SGD money market ETF debuts on SGX with initial AUM of S$100m

  • 📰 BusinessTimes
  • ⏱ Reading Time:
  • 37 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 18%
  • Publisher: 51%

대한민국 뉴스 뉴스

대한민국 최근 뉴스,대한민국 헤드 라인

THE first Singapore-domiciled money market exchange-traded fund (ETF) started trading on Monday with S$100 million in initial assets under management (AUM), the Singapore Exchange (SGX) said. Read more at The Business Times.

It added that the fund attracted"strong interest" from investors, demonstrating demand for the only money market ETF in South-east Asia.

Said Linus Lim, director and chief executive officer of Phillip Capital Management:"With Phillip SGD Money Market ETF, investors will be able to improve the yield pick-up on their funds without compromising on liquidity and manage their core investments through a single brokerage account. "We believe this will make a straightforward cash management tool for corporate treasurers and investors."

Michael Syn, head of equities at SGX, said the bourse is pleased to expand SGX's suite of fixed income ETFs at a time when investors are facing a"prolonged low-yield environment across international markets".For daily updates on weekdays and specially selected content for the weekend. Subscribe to

 

귀하의 의견에 감사드립니다. 귀하의 의견은 검토 후 게시됩니다.
이 소식을 빠르게 읽을 수 있도록 요약했습니다. 뉴스에 관심이 있으시면 여기에서 전문을 읽으실 수 있습니다. 더 많은 것을 읽으십시오:

 /  🏆 15. in KR

대한민국 최근 뉴스, 대한민국 헤드 라인

Similar News:다른 뉴스 소스에서 수집한 이와 유사한 뉴스 기사를 읽을 수도 있습니다.

Trump's COVID-19 diagnosis fuels uncertainty for skittish US stock marketInvestors are gauging how a potential deterioration in President Donald Trump's health could impact asset prices in coming weeks, as the U.S.
출처: ChannelNewsAsia - 🏆 6. / 66 더 많은 것을 읽으십시오 »

Vaccine prices will fall in a free marketTHERE is a growing consensus that one or more Covid-19 vaccines will become available at some point in early 2021. Within a year, many people in the United States, and some other countries, will be vaccinated. For some childhood diseases, the development of a vaccine was by itself decisive. But this may not be true of Covid-19, because adoption could be slow or effectiveness wane over time - or both. Read more at The Business Times.
출처: BusinessTimes - 🏆 15. / 51 더 많은 것을 읽으십시오 »